With regard to CRC, Zhou et al. [40] argued that MIR155HG, as an endogenous lncRNA, competed with annexin 2 (ANXA2) by combining with miR-650, thereby promoting M2 macrophage polarization and oxaliplatin resistance in CRC cells. This evidence concerns the gene ANXA2 and colorectal carcinoma.